Intensive Care National Audit & Research Centre (ICNARC)

What Intensive Care National Audit & Research Centre (ICNARC) does

ICNARC is an independent, not-for-profit scientific organisation and registered charity (charity number 1039417; company limited by guarantee 2946727), established in 1994 and headquartered at Napier House, 24 High Holborn, London. It operates as the designated national clinical audit body for critical care in England and Wales, conducting four main audit programmes — the Case Mix Programme (CMP), the National Cardiac Arrest Audit (NCAA), INICUA, and the Family Satisfaction Audit — alongside a dedicated research portfolio. Its core platform combines national data collection from participating NHS critical care units with proprietary case-mix adjustment methodology, quality indicators, and an Insights Platform for reporting. The Research Database operates under a Five Safes data governance framework, allowing approved researchers secure access to linked clinical data under Section 251 of the NHS Act 2006.

ICNARC's technology stack centres on longitudinal critical care data capture and benchmarking rather than commercial software development. The Case Mix Programme is the foundational asset, with continuous national coverage of adult critical care admissions since the 1990s. During the COVID-19 pandemic, ICNARC extended its infrastructure to deliver real-time surveillance reporting to NHS England, established daily data flows into the NHS England data lake from 25 March 2020, and integrated its data with NHS Digital Trusted Research Environment, the SAIL Databank in Wales, and the OpenSAFELY primary care platform. It also coordinated the UK arm of the global REMAP-CAP platform trial in partnership with Imperial College London, scaling UK participation from 10 sites pre-pandemic to 148 sites.

The organisation is funded by hospital subscriptions for audit services and by research grants from bodies such as NIHR; there are no commercial pricing models, equity funding, or non-NHS customers. Pricing is not publicly disclosed, and the entity operates as a Company Limited by Guarantee under trustee governance with 59 employees. Its partnerships are concentrated within the UK public sector and academic ecosystem, including NHS England, NHS Digital, NIHR, Imperial College London, and the RECOVERY trial consortium. Quantifiable impact includes its COVID-19 outcome analyses informing JCVI vaccination prioritisation and its earlier night-discharge research contributing to substantial increased investment in critical care services in England.

Name

Intensive Care National Audit & Research Centre (ICNARC)

Legal name

Intensive Care National Audit & Research Centre

Website

https://icnarc.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

ICNARC is an independent UK non-profit organisation, founded in 1994, that conducts national clinical audits and research on intensive care for NHS trusts across England and Wales, operating programmes such as the Case Mix Programme, NCAA, INICUA, and Family Satisfaction Audit.

Ownership category

akta.pro rank

Product category

Healthcare Clinical Audit and Research Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

• Clinical audit services
• Intensive care research
• Healthcare data analytics
• Critical care quality improvement
• National health audit

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels1 record

Marketing channels2 records

Core offering

ICNARC conducts national clinical audits and applied research for adult intensive care in the UK, operating flagship audit programmes (Case Mix Programme, National Cardiac Arrest Audit, INICUA, Family Satisfaction Audit) and the ICNARC Research Database. It enables participating NHS hospitals to benchmark outcomes against national data, supports quality improvement, and provides evidence to inform clinical guidelines and public health policy, including COVID-19 response and vaccination prioritisation.

Differentiator

Problem solved

Functional benefit

Products and services

• Case Mix Programme (CMP)

Quantifiable outcome

• ICNARC's data informed JCVI decisions on COVID-19 vaccination prioritization
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core, major and regional.

• Imperial College LondoncoreStrategic or Co-development PartnerICNARC, in partnership with Imperial College London, is the UK coordinating centre for the global REMAP-CAP platform trial evaluating interventions for community-acquired pneumonia and COVID-19. This partnership enabled rapid escalation from 10 to 148 UK sites during the pandemic.
• NHS EnglandcoreStrategic or Co-development PartnerPrior to the first confirmed case of COVID-19 in the UK, ICNARC was approached by NHS England to provide analyses on characteristics and outcomes of patients admitted to critical care. Regular daily data flows into the NHS England data lake commenced on 25 March 2020.
• NHS DigitalcoreTechnology or IntegrationRegular data flows established to NHS Digital Trusted Research Environment; patient data including NHS numbers processed for audit and research purposes under Section 251 approvals.
• RECOVERY TrialmajorStrategic or Co-development PartnerICNARC provided linked data from the Case Mix Programme to the RECOVERY trial and RECOVERY-RS clinical trials for COVID-19 research.
• SAIL Databank (Wales)regionalTechnology or IntegrationRegular data flows established to the SAIL Databank in Wales for research purposes.
• OpenSAFELY PlatformmajorTechnology or IntegrationCase Mix Programme data were linked with primary care data in the OpenSAFELY platform for COVID-19 research.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Optum (UnitedHealth Group): Large-scale US healthcare analytics and clinical research organization providing outcomes analytics, real-world evidence, and clinical decision support. Comparable in healthcare outcomes/RWE analytics capability, though at much larger scale and commercial scope.
• Premier Inc. US healthcare improvement company operating clinical benchmarking, outcomes research, and quality improvement programs across member hospitals. Provides comparable hospital benchmarking and clinical audit infrastructure at scale.
• NHS Digital: UK national health information partner that receives ICNARC's data flows and operates the Trusted Research Environment. A broader NHS data infrastructure provider with overlapping capabilities in health data analytics.
• NICE (National Institute for Health and Care Excellence): UK national body providing evidence-based guidance and quality standards for health and care. Adjacent comparator as a designated national body using data and evidence to influence NHS practice and policy.
• Dr Foster Intelligence (Telstra Health): UK-based healthcare analytics organization providing hospital benchmarking, clinical outcome analysis, and quality improvement data. Comparable in healthcare outcomes analytics but with a broader, commercial portfolio beyond critical care.
• CHKS (Capita Healthcare Decisions): UK healthcare benchmarking and quality improvement provider offering clinical analytics, hospital performance indicators, and outcome analysis. Comparable commercial analytics capability serving NHS hospitals.

Regional players

• Scottish Intensive Care Society Audit Group (SICSAG): Scotland's equivalent national intensive care audit program, providing critical care outcomes data for Scottish NHS boards. Direct regional peer offering comparable audit services in a separate UK jurisdiction.

Direct peers

• ANZICS CORE (Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation): Australian/NZ national intensive care audit body operating similar clinical audit programs (e.g., ANZICS APD) and patient outcome registries. Most direct international peer to ICNARC in mission, methodology, and stakeholder structure.
• National Cardiac Arrest Audit (NCAA): ICNARC-managed national audit specifically focused on cardiac arrest in UK hospitals. Closely related audit program with similar methodology, though technically part of the ICNARC portfolio.

Emerging players

• The Health Foundation: UK independent healthcare research charity funding quality improvement and health services research. Comparable as a UK healthcare research organization focused on improving NHS care quality and outcomes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/intensive-care-national-audit-and-research-centre

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intensive Care National Audit & Research Centre (ICNARC)